Qure.ai, a global healthcare AI company, has secured a $65 million Series D financing round to support global expansion, invest in foundational AI models, and enable med-tech company acquisitions.
Founded in 2016 by Prashant Warier Ph.D, the company aims to make healthcare more equitable and accessible globally. Qure’s automated interpretational device is designed to ease access to healthcare globally, which has become one of the world’s most deployed healthcare AI solutions.
The company’s series D funding round was spearheaded by 360 ONE Asset and Lightspeed, with the participation of other strategic investors, Kae Capital and Merck Global Health Innovation Fund. Existing investors Health Quad, Novo Holdings, and TeamFund also joined the round.
The successful round underscores the investors’ confidence in the company’s mission to revolutionize care for patients with chronic conditions such as lung cancer, stroke, and tuberculosis (TB) through its medical imaging AI, which helps clinicians detect and diagnose chronic medical conditions instantly.
Used in over 90 countries and across over 3000 medical facilities globally, Qure’s AI solutions help in the early detection and management of chronic medical conditions, providing diagnostic solutions for low-resourced and high-disease-burden populations.
Through early disease detection, AI solutions can help reduce mortality and morbidity due to early medical interventions.